
Shares of telehealth company Mangoceuticals MGRX.O, also known as MangoRx, rise as much as 9.8% to an over five-month high of $6.15; last up 4.9% in morning trade
Co says it is launching a women's telehealth brand called PeachesRx, to focus on personalized wellness and GLP-1 weight loss treatments
GLP-1 receptor agonists is a class of medication proven to aid weight loss by regulating appetite and glucose metabolism
Co aims to offer access by providing affordable and medically supervised treatments via its telemedicine platform
In the last 12 months, MGRX has risen ~31%